![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Novo Nordisk Pledges to Restrict Price Hikes to Single-Digit Increases
Novo Nordisk Pledges to Restrict Price Hikes to Single-Digit Increases
December 14, 2016
Novo Nordisk has committed to limiting the price hikes of its drugs to no more than single-digit increases each year — becoming the second drugmaker to make such a pledge.
The company’s president Jakob Riis released the plan to restrict increases in drug prices amid mounting criticism on the surge in treatment costs. The announcement comes three months after Allergan’s CEO Brenton Saunders made the same pledge.
Upcoming Events
-
21Oct